Skip to content

Central pathogenesis of male primary ejaculation dysfunction based on fMRI

Central pathogenesis of male primary ejaculation dysfunction based on fMRI

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068588
Enrollment
Unknown
Registered
2023-02-24
Start date
2023-02-14
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ejaculation Dysfunction

Interventions

Healthy Control:Brain functional MRI examination
Lifelong Premature Ejaculation:Brain functional MRI examination + drug therapy
Lifelong Delayed Ejaculation:Brain functional MRI examination + transcranial magnetic stimulation (TMS)

Sponsors

The Second Affiliated Hospital of Anhui Medical of University,
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of LPE patients:(1) Premature Ejaculation Diagnostic Tool score (PEDT) >11 points; (2) Intravaginal Ejaculatory Latency Time (IELT) <1min, measured by stopwatch; (3) No history of drug treatment. Our age range is 18-45 years old LDE inclusion criteria: (1) meet the diagnostic criteria of DE; (2) PEDT score <5; (3) There is no clear history of drug use or known medical history that may cause DE. Inclusion criteria of healthy control group (HCs) :(1) PEDT score <5; (2) Age, case number, handedness matched with LPE and LDE patients; (3) no history of drug use; (4) Healthy body, no other underlying diseases

Exclusion criteria

Exclusion criteria: Exclusion criteria for all subjects (including LPE, LDE patients and HCs) :(1) International Index of Erectile Function (IEF) <21; (2) a history of alcohol or drug abuse; (3) having a history of mental or neurological diseases; (4) History of head trauma or any contraindications to MRI scans; In addition, all participants were asked to complete the Hamilton Depression Scale (HAMD Scale), the Health Questionnaire Depression Scale (PHQ-9), and the Health Questionnaire Generalized Anxiety Disorder Scale GAD-7 as required by the study to investigate and assess the mental status of all participants. Inclusion criteria of healthy control group (HCs) :(1) PEDT score <5; (2) Age, case number, handedness matched with LPE and LDE patients; (3) no history of drug use; (4) Healthy body, no other underlying diseases

Design outcomes

Primary

MeasureTime frame
Functional connectivity differences in resting brain regions;White matter microstructure of the brain;Brain regions that are activated or suppressed in task state;

Secondary

MeasureTime frame
four Sex hormones;PEDT;CIPE Scale;HAMD Scale;PHQ-9;GAD-7;

Countries

China

Contacts

Public ContactCi Zou

The Second Affiliated Hospital of Anhui Medical University

zci2003@qq.com13515669967

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026